BioMarin Pharmaceutical stock kpis
Want to see BMRN full AI Analyst Report?
Revenue by Segment
Breaks down revenue across different business units, highlighting which products or services drive the most sales and indicating areas of growth or potential risk.
Voxzogo has emerged as BioMarin’s primary growth engine—a rapid commercial ramp since 2022 that now offsets the steady erosion in Kuvan, signaling successful commercialization but creating concentration risk around one newer product. Naglazyme and Palynziq are meaningful, rising contributors (Palynziq accelerating), while Brineura/Aldurazyme remain modestly steady and Roctavian/royalties are small and volatile. Key watcher for investors: sustainability of Voxzogo uptake, payor access and quarter-to-quarter volatility that could swing near-term results.
BMRN Revenue by Segment
| Date | Voxzogo | Naglazyme | Palynziq | Brineura | Aldurazyme | Kuvan | Roctavian | Firdapse | Royalty and Other | Galafold | Pombiliti + Opfolda |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $245.01M | $107.82M | $111.03M | $52.71M | $56.60M | $22.95M | $738.00K | $0.00 | $11.57M | $151.83M | $48.59M |
| Jun 30, 2026 | $252.53M | $135.25M | $135.17M | $51.37M | $43.54M | $24.44M | $11.71M | $0.00 | $5.32M | $0.00 | $0.00 |
| Mar 31, 2026 | $219.88M | $130.07M | $89.56M | $47.10M | $36.74M | $23.88M | $2.64M | $0.00 | $6.13M | $0.00 | $0.00 |
| Dec 31, 2025 | $273.00M | $120.00M | $125.00M | $49.00M | $49.00M | $23.00M | $13.00M | $0.00 | $15.24M | $0.00 | $0.00 |
| Sep 30, 2025 | $218.00M | $122.00M | $109.00M | $48.00M | $54.00M | $24.00M | $3.00M | $0.00 | $15.32M | $0.00 | $0.00 |
| Jun 30, 2025 | $221.39M | $128.87M | $105.94M | $48.69M | $56.44M | $27.03M | $9.20M | $0.00 | $12.43M | $0.00 | $0.00 |
| Mar 31, 2025 | $214.00M | $114.00M | $93.00M | $40.00M | $49.00M | $25.00M | $11.00M | $0.00 | $10.50M | $0.00 | $0.00 |
| Dec 31, 2024 | $208.00M | $110.00M | $100.00M | $48.00M | $39.00M | $28.00M | $11.00M | $0.00 | $11.68M | $0.00 | $0.00 |
| Sep 30, 2024 | $189.80M | $131.90M | $90.60M | $37.00M | $71.00M | $28.10M | $7.20M | $0.00 | $11.90M | $0.00 | $0.00 |
| Jun 30, 2024 | $183.90M | $132.00M | $88.30M | $45.30M | $38.60M | $28.60M | $7.40M | $0.00 | $9.90M | $0.00 | $0.00 |
| Mar 31, 2024 | $152.90M | $105.60M | $75.70M | $39.00M | $35.30M | $35.90M | $800.00K | $0.00 | $11.00M | $0.00 | $0.00 |
| Dec 31, 2023 | $145.70M | $98.30M | $87.80M | $43.60M | $42.70M | $36.70M | $2.70M | $0.00 | $13.10M | $0.00 | $0.00 |
| Sep 30, 2023 | $123.00M | $108.90M | $78.90M | $41.00M | $13.80M | $42.90M | $800.00K | $0.00 | $13.10M | $0.00 | $0.00 |
| Jun 30, 2023 | $113.30M | $90.10M | $74.90M | $38.10M | $40.30M | $50.60M | $0.00 | $0.00 | $10.60M | $0.00 | $0.00 |
| Mar 31, 2023 | $87.80M | $123.00M | $62.40M | $39.10M | $34.40M | $50.50M | $0.00 | $0.00 | $10.00M | $0.00 | $0.00 |
| Dec 31, 2022 | $66.80M | $100.50M | $72.30M | $42.60M | $37.70M | $53.60M | $0.00 | $0.00 | $12.00M | $0.00 | $0.00 |
| Sep 30, 2022 | $48.30M | $99.50M | $66.20M | $37.80M | $29.00M | $57.00M | $0.00 | $0.00 | $12.00M | $0.00 | $0.00 |
| Jun 30, 2022 | $34.40M | $115.80M | $61.60M | $37.70M | $37.30M | $57.60M | $0.00 | $0.00 | $16.10M | $0.00 | $0.00 |
| Mar 31, 2022 | $19.70M | $128.00M | $54.90M | $36.20M | $24.40M | $59.30M | $0.00 | $0.00 | $13.80M | $0.00 | $0.00 |
| Dec 31, 2021 | $5.70M | $83.10M | $63.80M | $37.40M | $20.20M | $68.50M | $0.00 | $0.00 | $14.60M | $0.00 | $0.00 |
| Sep 30, 2021 | $100.00K | $71.20M | $60.70M | $33.00M | $24.40M | $67.70M | $0.00 | $0.00 | $14.90M | $0.00 | $0.00 |
| Jun 30, 2021 | $0.00 | $118.80M | $58.90M | $30.30M | $28.10M | $78.80M | $0.00 | $0.00 | $15.00M | $0.00 | $0.00 |
| Mar 31, 2021 | $0.00 | $107.30M | $54.00M | $27.30M | $50.00M | $70.80M | $0.00 | $0.00 | $18.30M | $0.00 | $0.00 |
| Dec 31, 2020 | $0.00 | $119.70M | $49.60M | $35.00M | $1.20M | $89.10M | $0.00 | $0.00 | $15.10M | $0.00 | $0.00 |
| Sep 30, 2020 | $0.00 | $76.30M | $46.10M | $25.50M | $41.00M | $124.00M | $0.00 | $0.00 | $16.00M | $0.00 | $0.00 |
| Jun 30, 2020 | $0.00 | $81.00M | $40.60M | $25.80M | $32.30M | $122.60M | $0.00 | $0.00 | $10.50M | $0.00 | $0.00 |
| Mar 31, 2020 | $0.00 | $114.30M | $34.60M | $24.00M | $55.70M | $122.00M | $0.00 | $1.30M | $13.00M | $0.00 | $0.00 |
| Dec 31, 2019 | $0.00 | $94.90M | $31.60M | $25.20M | $23.90M | $122.60M | $0.00 | $6.10M | $17.90M | $0.00 | $0.00 |
